AI-generated working estimate based on public information / opinion & commentary, not a statement of fact / corrections & rebuttals welcome

日本語 / English

Home / East & Southeast Asia · Japan / Health-tech (pharmacy DX) · Private

Kakehashi

Turning pharmacies from “a place to hand over medicine” into “a place for personal care” (Musubi)

B
NARRATIVE VALUE
Certainty
●●○ medium
ABCDEFG

There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter

As of: 2026-Q2Status: ActiveCeiling reason: No confirmed −
History2026-Q2BHistory grows each quarter

Kakehashi: Turning pharmacies from “a place to hand over medicine” into “a place for personal care” (Musubi). Raised in a family of medical professionals and a medical rep at Takeda, Yutaka Nakao founded Kakehashi in 2016. He sought to close the gap between reality and the direction set by the Ministry of Health, Labour and Welfare's 2015 “Vision of Pharmacies for Patients” — turning pharmacies from “a place that just hands over medicine” into “a place that delivers added value to patients,” from product-facing to person-facing work. The pharmacy-experience assistant “Musubi,” launched in 2017, presents medication guidance tailored to each patient on screen and automatically drafts the medication record on the spot. It compresses clerical work that took hours each day and gives pharmacists back time to face patients. It has spread to over 10,000 stores across all 47 prefectures, under the banner “make Japan's healthcare experience supple.” The letter is B; certainty is medium. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q2; estimate based on public information.)

Main narrative

Raised in a family of medical professionals and a medical rep at Takeda, Yutaka Nakao founded Kakehashi in 2016. He sought to close the gap between reality and the direction set by the Ministry of Health, Labour and Welfare's 2015 “Vision of Pharmacies for Patients” — turning pharmacies from “a place that just hands over medicine” into “a place that delivers added value to patients,” from product-facing to person-facing work.

The pharmacy-experience assistant “Musubi,” launched in 2017, presents medication guidance tailored to each patient on screen and automatically drafts the medication record on the spot. It compresses clerical work that took hours each day and gives pharmacists back time to face patients. It has spread to over 10,000 stores across all 47 prefectures, under the banner “make Japan's healthcare experience supple.”

One person’s story (N1)

+ before → after

Between visits, patients may take medicine wrongly or fail to notice side effects. Kakehashi's “Pocket Musubi” asks via LINE, “Have you felt dizzy?” and the like, and sends an alert to the pharmacist if there are dangerous signs. It catches oversights in the “blank period” where a clinician's eyes can't easily reach, so action can be taken before things turn serious.

Source nature: LoveTechMedia / P3 trade media. Positive effects are not used to offset negatives.

Positive / negative effects

+ effects

  • Won the Grand Prize at the “Japan Healthcare Business Contest 2019” organized by the Ministry of Economy, Trade and Industry.P1 cert/award/academic/international body / 経済産業省

− effects (confirmed)

  • No confirmed −.
Watching (unconfirmed; not counted in the assessment)
  • Independent verification of patient-data handling and treatment-outcome improvement

A second look

Whether medication follow-up and data use improve patients' treatment outcomes, and whether this is independently verified.

Sources

+N1LoveTechMedia|電子薬歴Musubi ハイリスク薬の新機能|2019|https://lovetech-media.com/news/family/20190329_02/
+ effect経済産業省|ジャパン・ヘルスケアビジネスコンテスト2019|2019|Source URL to be confirmed

How to read this assessment

A Independently verified +, with no confirmed −
B Leans +, with independent backing
C Mixed. A confirmed − sets the ceiling, or much is unverified
D A serious confirmed − sets the ceiling
E A serious − reaches the core of the organization
F Serious and systemic, with little redeeming +
G Only extreme cases
Out of scope An entity whose core purpose is illegal
On hold Independent evidence is scarce on both + and −
  • Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
  • The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
  • Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
  • The letter (assessment) and certainty (how reliable the information is) are separate axes.

This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.

Terms: Narrative Value = an assessment (A–G) of the distance between the story an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q2 | Back to top